Stocks in Play

Oncolytics Biotech Inc

09:23 AM EST - Oncolytics Biotech Inc : Announces ASCO Abstracts highlight Pelareorep's potential in pancreatic icancer and immunotherapeutic mechanism of action. Trial-in-progress abstract highlights new cohort that could expand the company's pancreatic cancer program. Pelareorep's ability to expand TILs highlights its immunotherapeutic mechanism of action and potential as a backbone immunotherapy for multiple indications. Oncolytics Biotech Inc shares T.ONC are trading unchanged at $1.45.

Full Press Release: